Regeneron Pharmaceuticals (REGN) stock price is up over 1% so far today. The REGN earnings report indicated $23.72 in EPS and $4.95B in revenue, beating estimates. Kevin Kelly weighs in on Regeneron's fourth quarter antibody revenue totaling $2.3B. Next, George Tsilis places an example option trade to sell the REGN iron condor.
04 Feb 2022
Market On Close
05 May 2022
Morning Trade Live
18 Mar 2022
Trading 360
23 Feb 2022
Morning Trade Live
10 Mar 2022
Market On Close
23 Feb 2022
Morning Trade Live
10 May 2022